In the veterinary literature, COX-2 overexpression has been documented in canine mammary carcinoma, cutaneous hemangiosarcoma, squamous cell carcinoma, renal cell carcinoma, mast cell tumors, cutaneous, and oral melanomas [19–24]. Here, PTGS2 is linked to squamous cell carcinoma.